In contrast, when recipient mice were irradiated 13 Gy, the early developed GVHD showed higher mortality with more severe GVHD scores in IL-2 treated recipients than vehicle treated recipients (Figures 5C, D). The gene discussed is IL2; the disease is graft versus host disease.